Establishment Labs Holdings Inc (ESTA)

NASD · Healthcare · Medical Devices · USA

Establishment Labs Holdings Inc is a mid cap company (market value between $2 billion and $10 billion) in the Medical Devices industry.

Establishment Labs is a medical technology company that develops and sells silicone gel-filled breast implants under the Motiva brand for aesthetic augmentation and reconstruction. The product portfolio features proprietary technologies such as SmoothSilk surface treatment and Qid RFID identification. Motiva Implants are distributed globally through exclusive distributors and direct sales channels.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Establishment Labs Holdings Inc stock.

Our verdict on ESTA

Overvalued: intrinsic value $8.40 per share, market price $69.51, margin of safety -727.5% (as of 2026-11-17).

A 1.6x revenue multiple, discounted for its losses, values the shares at $8.40; the price of $69.51 is 727% above that value.

ETFs with the most weight in ESTA

17 more funds hold it; the full list is part of the paid plan.

More on ESTA

Browse

Peers in Medical Devices

All 140 Medical Devices stocks

Cheaper than ESTA in Medical Devices

54 more in this industry show a wider margin of safety.

Is ESTA undervalued or overvalued?

ESTA is overvalued (as of the 2026-11-17 close). A 1.6x revenue multiple, discounted for its losses, values the shares at $8.40; the price of $69.51 is 727% above that value.

What is the intrinsic value of ESTA?

$8.40 per share (as of the 2026-11-17 close), against a market price of $69.51. That is a margin of safety of -727.5%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.